Pfizer's tick-borne encephalitis vaccine TICOVAC receives FDA approval

CompilationFan Dongdong

A few days ago, the U.

Dr.

Tick-borne encephalitis is a viral infection, and the virus is transmitted to humans mainly through insect bites

According to the recommendations of the European Center for Disease Control and Prevention (ECDC), people who live or travel to areas where tick-borne encephalitis is endemic should be vaccinated

The company said that the vaccine was developed with a virus similar to tick-borne encephalitis virus, which can induce patients to produce neutralizing antibodies against tick-borne encephalitis virus

In addition, the trial also found that patients vaccinated with TICOVAC vaccine are generally well tolerated and there are no unexpected adverse events (AE) or serious adverse events related to the vaccine

Not long ago, the FDA also approved the revised emergency use authorization of Pfizer and BioNTech's COVID-19 vaccine, allowing patients with weakened immune functions to receive a third booster injection

Reference source:

1.

2.